RiverVest
RiverVest Venture Partners is a venture capital firm founded in 2000 that builds and funds life‑science companies, focused on biopharmaceuticals and medical devices. The firm leads financings, founds companies, provides board and operational support, and leverages scientific, clinical, regulatory and reimbursement expertise to advance products that address unmet medical needs while delivering returns to investors.
Industries
Nr. of Employees
small (1-50)
RiverVest
101 S. Hanley Road, Suite 1850, St. Louis, MO 63105
Portfolio
No‑implant approach addressing chronic heart failure; referenced in firm 'Portfolio Company Spotlight'.
#Medical Device
Portfolio company with recent leadership transition (press release referenced).
#Biopharma
Developing inhaled therapies for pulmonary fibrosis; multiple financing and clinical milestones referenced.
#Biopharma
Developing a biowearable platform for metabolic health; announced Series C and strategic collaborations.
#Medical Device
Developing monoclonal antibodies for hepatitis B and D; received FDA breakthrough and EMA designations and advanced clinical trials.
#Biopharma
Developing GLM101 for PMM2‑CDG; announced Series C financing and clinical progress.
#Biopharma
No‑implant approach addressing chronic heart failure; referenced in firm 'Portfolio Company Spotlight'.
#Medical Device
Portfolio company with recent leadership transition (press release referenced).
#Biopharma
Developing inhaled therapies for pulmonary fibrosis; multiple financing and clinical milestones referenced.
#Biopharma
Developing a biowearable platform for metabolic health; announced Series C and strategic collaborations.
#Medical Device
Developing monoclonal antibodies for hepatitis B and D; received FDA breakthrough and EMA designations and advanced clinical trials.
#Biopharma
Developing GLM101 for PMM2‑CDG; announced Series C financing and clinical progress.
#Biopharma